Shenzhen Hepalink Pharmaceutical Group Co Ltd 2022 Sustainability Report
Company: Shenzhen Hepalink Pharmaceutical Group Co Ltd
Sector: Manufacturing
Country: China
Year: 2022
Type: Sustainability Report
Pages: 50
The report covers the Group's 2022 ESG performance and describes a materiality assessment that identified 22 issues, including waste control and occupational safety. It reports total GHG emissions of 58,349.4 tonnes of carbon dioxide equivalent, including 24,355.2 tonnes of Scope 1 emissions and 33,994.2 tonnes of Scope 2 emissions. All Shenzhen factories obtained Clean Production Certification during the year, while the Group donated pandemic supplies and equipment and its US industrial park donated US$9,263 to local welfare organisations.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.